Sinopac Venture

Investor type

PE

Founded

2003

AUM

-

Location

Taipei, Taipei, Taiwan

Investment Ticket

$1-5 m

Investment Stage

Late Stage (Series C+)

Region of investment

Asia
Investor profile last updated: 21 August, 2026

Profile

SinoPac Venture Capital was established in January 2003. In recent years, we have focused investments in the ecommerce, FinTech, Industry 4.0, automation, cultural and creative industries, and biomedical industries. Concurrently, with greater cross-straits interaction, we also proactively seek cooperating partners in China to expand our scale.





SinoPac Venture Capital investment targets are mainly early stage, startup, and development phase enterprises. Secondarily, we also invest in mature and pre-IPO enterprises, with the aim of maintaining a stable stream of exits from each phase, enabling sustainable and consistent income streams over time.

Industry

Biotechnology Business Services (B2B) E-commerce/Marketplace Fintech Financial Services Healthcare Services Medical Devices Other Pharmaceuticals MedTech Life Sciences Infrastructure HealthTech

Contacts

Name
Title
Email
avatar
Eric Chuang President
President
-
avatar
Shi-Kuan Chen Chairman
Chairman
-
Upgrade to see contacts
avatar
vcAVZUu20f3Xg9a7 vcAVZUu20f3Xg9a7
vcAVZUu20f3Xg9a7
avatar
vcAVZUu20f3Xg9a7 vcAVZUu20f3Xg9a7
vcAVZUu20f3Xg9a7
avatar
vcAVZUu20f3Xg9a7 vcAVZUu20f3Xg9a7
vcAVZUu20f3Xg9a7
Investment-team contacts for Sinopac Venture — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Sinopac Venture

Sinopac Venture is a private equity firm. It backs companies at Late Stage (Series C+), writing tickets of $1-5 m.
Sinopac Venture is located in Taipei, Taipei, Taiwan.
Sinopac Venture was founded in 2003.
Sinopac Venture invests in companies and startups in Biotechnology, Business Services (B2B), E-commerce/Marketplace, Fintech, Financial Services, Healthcare Services, Medical Devices, Other, Pharmaceuticals, MedTech, Life Sciences, Infrastructure, HealthTech.
Sinopac Venture invests in companies and startups in Asia.
Sinopac Venture invests in companies and startups at Late Stage (Series C+).
Sinopac Venture usually invests $1-5 m on average.
Sinopac Venture can be reached through its website sinopac.com/en/index.html. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Sinopac Venture — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Sinopac Venture directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.